Godavari Biorefineries Ltd
Incorporated in 1939, Godavari Biorefineries Ltd is a manufacturer of Bio-based Chemicals and Ethanol[1]
- Market Cap ₹ 1,496 Cr.
- Current Price ₹ 294
- High / Low ₹ 409 / 145
- Stock P/E
- Book Value ₹ 153
- Dividend Yield 0.00 %
- ROCE 5.79 %
- ROE -3.65 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Debtor days have improved from 34.9 to 27.0 days.
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 5.09% over past five years.
- Company has a low return on equity of 0.57% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
1,459 | 1,538 | 1,702 | 2,015 | 1,687 | 1,870 | |
1,356 | 1,381 | 1,568 | 1,867 | 1,553 | 1,767 | |
Operating Profit | 103 | 158 | 135 | 147 | 134 | 104 |
OPM % | 7% | 10% | 8% | 7% | 8% | 6% |
14 | 8 | 6 | 7 | 14 | 17 | |
Interest | 69 | 72 | 60 | 73 | 76 | 72 |
Depreciation | 45 | 47 | 48 | 50 | 60 | 50 |
Profit before tax | 3 | 46 | 33 | 32 | 12 | -2 |
Tax % | -24% | 41% | 40% | 38% | 1% | 1,421% |
4 | 27 | 19 | 20 | 12 | -23 | |
EPS in Rs | 0.97 | 6.47 | 4.64 | 4.68 | 2.93 | -4.57 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 5% |
3 Years: | 3% |
TTM: | 11% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -289% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 2% |
3 Years: | 1% |
Last Year: | -4% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
Equity Capital | 42 | 42 | 42 | 42 | 42 | 51 |
Reserves | 385 | 412 | 431 | 448 | 459 | 731 |
589 | 569 | 637 | 736 | 655 | 490 | |
418 | 419 | 623 | 518 | 836 | 683 | |
Total Liabilities | 1,434 | 1,442 | 1,733 | 1,744 | 1,992 | 1,955 |
735 | 708 | 667 | 866 | 850 | 878 | |
CWIP | 17 | 9 | 50 | 17 | 29 | 22 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 |
683 | 725 | 1,016 | 860 | 1,113 | 1,055 | |
Total Assets | 1,434 | 1,442 | 1,733 | 1,744 | 1,992 | 1,955 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
250 | 130 | 45 | 197 | 186 | 6 | |
-23 | -7 | -47 | -214 | -44 | -69 | |
-226 | -121 | 4 | 28 | -151 | 64 | |
Net Cash Flow | 1 | 2 | 3 | 11 | -10 | 1 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
Debtor Days | 31 | 40 | 39 | 37 | 41 | 27 |
Inventory Days | 130 | 146 | 200 | 137 | 250 | 195 |
Days Payable | 123 | 132 | 176 | 105 | 195 | 140 |
Cash Conversion Cycle | 39 | 55 | 63 | 68 | 95 | 82 |
Working Capital Days | 44 | 57 | 72 | 52 | 50 | 70 |
ROCE % | 12% | 9% | 9% | 7% | 6% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
31 May - Q4 FY25 earnings: 11% revenue growth, 3x EBITDA target by FY29, 200kL/day grain ethanol plant by Q4 FY26.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
30 May - Scheduled analyst meeting on June 6, 2025; investor presentation uploaded online.
-
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
27 May - Monitoring Agency Report: Rs.1.40 Cr excess IPO funds used for general corporate purposes, within SEBI norms.
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)
26 May - Revised Q4 FY25 financial results correcting tax expense classification; no impact on profitability.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
26 May - Revised Investor Presentation for the Q4 and FY 25
Annual reports
Concalls
-
May 2025Transcript PPT REC
-
May 2025TranscriptNotesPPT
-
Feb 2025Transcript PPT REC
-
Nov 2024Transcript PPT REC
Business Overview:[1][2]
a) GBL is a part of the Somaiya group which holds 63.31% equity stake in the company through entities.
b) It has an Integrated Bio-refinery across value chain viz. Sugar, Branded Sugar, Ethanol, Bio Based Chemicals & Power
c) It has India’s first bio-based Ethyl Vinyl Ether (EVE) manufacturing facility in India
d) Company is the largest Manufacturer of MPO in India in terms of installed capacity
e) It is one of only 2 Manufacturers of natural 1,3 Butylene Glycol (BG) globally
f) The company has an in-house retail brand Jivana for sale of sugar, turmeric, and salt in Rajasthan Maharashtra, Karnataka, and Gujarat.